Rituxan

Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Fierce Pharma
Mon, 02/1/16 - 01:49 pm
Roche
drug pricing
Rituxan
Avastin
Herceptin
Roche readies new drugs in two-year window before copycats hit
Yahoo/Reuters
Thu, 07/23/15 - 12:06 pm
Roche
biosimilars
Herceptin
Rituxan
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Biogen Goes Generic
Investopedia
Fri, 04/10/15 - 10:12 am
Biogen
generics
Rituxan
anti-TNF
SB4
biosimilars
Remicade
SB2
Enbrel
Rituxan may have rare-disease use
Medical Marketing and Media
Tue, 04/7/15 - 09:55 am
Rituxan
Roche
EGPA
Genentech denies knowledge of distribution-related problems
BioPharma Dive
Thu, 03/5/15 - 11:12 am
Genentech
distribution
Avastin
Herceptin
Rituxan
Genentech Distribution Shift for Cancer Meds Delays Patient Care: Survey
WSJ Pharmalot
Mon, 03/2/15 - 12:29 pm
Genentech
Avastin
Rituxan
Herceptin
distribution
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Roche's Genentech defends supply shift for top cancer drugs
Yahoo/Reuters
Tue, 11/25/14 - 09:37 am
Roche
Genentech
cancer
Avastin
Herceptin
Rituxan
distribution
Roche nabs European approval for time-saving formulation of Rituxan
Fierce Pharma
Fri, 03/28/14 - 10:56 am
Roche
Europe
Rituxan
MabThera
The 10 best-selling drugs of 2013
Fierce Pharma
Tue, 03/25/14 - 10:07 am
Seretide
Rituxan
Remicade
MabThera
Lantus
Humira
Herceptin
Enbrel
Crestor
Avastin
Advair
Abilify
New Roche leukemia drug shows clear advantage over Rituxan-study
Yahoo/Reuters
Thu, 11/7/13 - 09:47 am
Roche
Rituxan
GA101
Gazyva
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Thu, 10/10/13 - 08:13 am
Gilead Sciences
Idelalisib
Rituxan
chronic lymphocytic leukemia
Boxed Warning of HBV Risk Added to Rituxan, Arezerra
Med Page Today
Thu, 09/26/13 - 10:28 am
warnings
Rituxan
hepatitis B
Arezerra
ofatamumab
rituximab
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
chronic lymphocytic leukemia
Sanofi
Campath
GSK
Arzerra
Roche
Rituxan
ibrutinib
Pharmacyclics
obinutuzumab
JNJ
Genmab
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Roche Says GA101 Beat Rituxan in Test as Replacement Drug
Bloomberg
Wed, 07/24/13 - 09:57 am
Roche
GA101
Rituxan
chronic lymphocytic leukemia
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Report: Don't count Celltrion out of Rituxan biosim race
Fierce Biotech
Fri, 04/19/13 - 12:08 pm
Celltrion
biosimilars
Rituxan
Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Bloomberg
Thu, 03/7/13 - 11:43 am
Rituxan
biosimilars
Novartis
Sandoz

Pages